Roche Expands AI Infrastructure with NVIDIA Partnership, Creating Largest Pharmaceutical AI Factory

Deep News03-17

Swiss pharmaceutical giant Roche announced on Monday a major expansion of its global artificial intelligence infrastructure, deploying a large-scale AI factory powered by NVIDIA's latest generation of accelerated computing and AI technology.

The expansion adds 2,176 NVIDIA Blackwell GPUs, deployed in on-premises and hybrid cloud environments across the United States and Europe. This brings Roche's total available GPU count to over 3,500, establishing what is currently the largest disclosed GPU computing cluster in the pharmaceutical industry.

This move signifies a new phase in the strategic partnership between Roche and NVIDIA that began in 2023. The AI factory will be deeply integrated across Roche's entire value chain, with the goal of accelerating the development of new drugs, clinical trials, and diagnostic solutions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment